Treadmill Training and Quality of Life in Parkinson's Disease

This study has been completed.
Sponsor:
Information provided by:
Universidade Federal de Sao Carlos
ClinicalTrials.gov Identifier:
NCT00890669
First received: April 28, 2009
Last updated: May 1, 2009
Last verified: May 2009

April 28, 2009
May 1, 2009
August 2007
Not Provided
The quality of life was measured through Parkinson Disease Questionnaire (PDQ-39). [ Time Frame: 4 times, once before treatment, and 3 after each treatment phase. ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00890669 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Treadmill Training and Quality of Life in Parkinson's Disease
Treadmill Walking Training With Additional Body Load Improves Quality of Life in Subjects With Parkinson's Disease

Parkinson's disease (PD) causes motor and non-motor impairments that affect the quality of life of the subjects. The purpose was to assess the effects of treadmill walking training with additional body load on the quality of life and motor symptoms of the subjects with PD.

Methods: Nine subjects with PD, Hoehn and Yahr stages 2 through 3, not demented and with capability to ambulate independently voluntarily participate in this study. The training program was divided into three phases (A1-B-A2): treadmill training with additional body load (A1), control condition (conventional physical therapy group) (B) and treadmill training with load again (A2). Each phase lasted six weeks. The quality of life and motor symptoms were assessed by PDQ-39 and UPDRS, respectively. Both evaluations and training were performed during on-phase of the medication cycle.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Parkinson's Disease
Other: Treadmill walking training with additional body load

The training program was divided into three phases (A1-B-A2):

  • treadmill training with additional body load (A1),
  • control condition (conventional physical therapy group) (B). and
  • treadmill training with additional body load again (A2).

Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle.

Experimental: PD Group
Nine subjects with idiopathic PD, previously diagnosed by one specialist physician participated in this study.
Intervention: Other: Treadmill walking training with additional body load
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
9
December 2008
Not Provided

Inclusion Criteria:

  • Hoehn and Yahr (H-Y) stages 2 through 3
  • Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level)
  • Capacity to ambulate independently for at least 10 meters

Exclusion Criteria:

  • Change medication (dopaminergic) during the study period
  • Use treadmill for at least six months prior to the study
  • Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the accomplishment of the training
Both
51 Years to 81 Years
No
Contact information is only displayed when the study is recruiting subjects
Brazil
 
NCT00890669
234/07, CEP/UFSCar
No
Nadiesca Taisa Filippin, Universidade Federal de São Carlos
Universidade Federal de Sao Carlos
Not Provided
Principal Investigator: Nadiesca T Filippin, MSc Universidade Federal de Sao Carlos
Study Chair: Rosana Mattioli, PhD Universidade Federal de Sao Carlos
Study Director: Paula H Lobo da Costa, PhD Universidade Federal de Sao Carlos
Universidade Federal de Sao Carlos
May 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP